Cumberland Pharmaceuticals Inc. Revenue 2009–2025
Cumberland Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cumberland Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 9.1 M, a 22.04% decrease year-over-year.
- Cumberland Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 40.0 M, a 6.55% increase year-over-year.
- Cumberland Pharmaceuticals Inc. annual revenue for 2025 was 44.5 M, a 17.57% increase from 2024.
- Cumberland Pharmaceuticals Inc. annual revenue for 2024 was 37.9 M, a 4.26% decrease from 2023.
- Cumberland Pharmaceuticals Inc. annual revenue for 2023 was 39.6 M, a 5.85% decrease from 2022.
- Cumberland Pharmaceuticals Inc. annual revenue for 2022 was 42.0 M.
Cumberland Pharmaceuticals Inc. (CPIX) — Frequently Asked Questions
Cumberland Pharmaceuticals Inc. (CPIX) is a publicly traded US company. It has a market capitalization of $84M. In fiscal 2025 it reported revenue of $45M and net income of -$3M. Explore CPIX's stock price, financial statements, earnings history, margins and key ratios below.
What is Cumberland Pharmaceuticals Inc.'s market cap?
Cumberland Pharmaceuticals Inc. (CPIX) has a market capitalization of $84M.
What is the CPIX stock price?
CPIX trades at $5.67 (+3.47% on the day).
How much revenue does Cumberland Pharmaceuticals Inc. make?
Cumberland Pharmaceuticals Inc. reported revenue of $45M in fiscal 2025.
Is CPIX profitable?
In fiscal 2025, Cumberland Pharmaceuticals Inc. reported net income of -$3M.